Search for: "SANOFI INC."
Results 1 - 20
of 428
Sorted by Relevance
|
Sort by Date
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and… [read post]
26 Dec 2010, 9:59 pm
The appeal arose from a dispute between Sun and Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Aventis U.S. [read post]
21 Feb 2021, 9:59 pm
Noonan -- A little less than four years ago, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
12 Mar 2024, 9:13 pm
Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S. [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
19 Nov 2017, 9:05 pm
Sanofi that brought clarity to how the Court (and U.S. [read post]
14 Nov 2013, 9:59 pm
By Donald Zuhn -- Last week, in Sanofi-Aventis v. [read post]
28 Sep 2023, 6:22 am
Baxalta Inc., v. [read post]
28 Sep 2023, 6:22 am
Baxalta Inc., v. [read post]
28 Sep 2023, 6:22 am
Baxalta Inc., v. [read post]
2 Aug 2023, 11:05 am
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
20 Oct 2010, 7:05 am
The following is excerpted from an October 20, 2010 article by Victoria Slind-Flor at Bloomberg: Sanofi-Aventis SA won a $442 million judgment against Apotex Inc. in a lawsuit over the patent for the blood thinner Plavix. [read post]
7 Nov 2008, 4:11 am
In a 7-0 judgment on 6 Nov 08, the Canadien Supreme Court rejected a request from Apotex Inc. to invalidate Sanofi's patent for an anti-coagulant drug (Plavix) used to combat cardiovascular degeneration.Coverage by Kirk Makin in the Globe and Mail did NOT get to the heart of this court battle involving patenting of racemates vs. patenting of enantiomers:Judge Rothstein said that in case of Sanofi's anti-coagulant drug - marketed under the name, Plavix - the… [read post]
10 Sep 2009, 9:59 pm
Sandoz, Inc.(1), arose as the result of ANDA filings by several Defendants for oxaliplatin, the active ingredient in Sanofi's Eloxatin ® colorectal cancer drug. [read post]
19 Feb 2008, 1:23 am
That case is titled: Safety Syringes, Inc. v. [read post]
9 Feb 2007, 11:37 am
Singer In a February 9, 2007 press release, Sanofi-Aventis announced that it has lost its patent infringement suit against generic drugmakers Amphastar Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd., filed in the U.S. [read post]
4 Dec 2023, 10:00 pm
Sanofi , 143 S. [read post]
19 Jun 2007, 9:45 pm
Sanofi and BMS filed the action in March of 2002, contending that... [read post]
18 Jan 2015, 9:06 pm
LLC; Aventis Pharma S.A.; Sanofi • Defendants: Apotex Corp.; Apotex Inc. [read post]
16 Jan 2019, 9:42 pm
Noonan -- The Supreme Court denied certiorari last week in Amgen Inc. v. [read post]
